Access

Article

Nature 427, 537-541 (5 February 2004) | doi:10.1038/nature02214;

Open Innovation Challenges

naturejobs

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Coumarin derivatives such as warfarin represent the therapy of choice for the long-term treatment and prevention of thromboembolic events. Coumarins target blood coagulation by inhibiting the vitamin K epoxide reductase multiprotein complex (VKOR).

, , , , , , , , , , , &

Top